Four 1,3-disubstituted benzimidazolium salts: 1,3-diisopropylbenzimidazolium iodide (1), 1,3-diisopropylbenzimidazolium aluminum tetraiodide (2), 1,3-diisopropylbenzimidazolium triiodide (3), and 1,3-diisopropylbenzimidazolium tetrakis[3,5-bis(trifluoromethyl)phenyl]borate (4) have been characterized using single X-ray diffraction analysis. Compounds 2–4 are new and are characterized by NMR and IR spectroscopy. Compound 2 was prepared by reacting 1 with aluminum triiodide and compound 4 in a metathesis reaction of 1 with sodium tetrakis[3,5-bis(trifluoromethyl)phenyl]borate, giving yields of 96% and 93%, respectively. Compound 3 was prepared by reacting 1 with 1 eq. of iodine and was isolated in 34% yield. Compound 1 crystallizes in the Orthorhombic space group P2 1 2 1 2 1 with an asymmetric unit consisting of one benzimidazolium cation and one iodine anion. Compound 2 crystallizes in the Monoclinic space group P2 1 / n with an asymmetric unit consisting of one benzimidazolium cation and one aluminum tetraiodide anion. Compound 3 crystallizes in the Monoclinic space group C2/ c with an asymmetric unit consisting of one and one-half benzimidazolium cations and one and one-half triiodide anions. Compound 4 crystallizes in the Triclinic space group P-1 with an asymmetric unit consisting of one benzimidazolium cation and one tetrakis[3,5-bis(trifluoromethyl)phenyl]borate anion. The NCN angles in all four compounds are approximately 110°, which is consistent with literature values. Stacking and halogen and hydrogen bonding interactions in the series are also discussed.
No takes yet. Share an insight, caveat, or question.
McClennan et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: